Back to News
Market Impact: 0.6

DHL is on customs agent hiring spree as Trump's trade war, reshoring bring big changes to U.S. shipping

LLYWFC
Trade Policy & Supply ChainTax & TariffsTransportation & LogisticsCompany FundamentalsArtificial IntelligenceTechnology & InnovationHealthcare & BiotechAutomotive & EV
DHL is on customs agent hiring spree as Trump's trade war, reshoring bring big changes to U.S. shipping

DHL Global Forwarding CEO Tim Robertson reports an "atypical" peak shipping season with "incredibly soft" U.S.-bound volumes, experiencing up to 20% year-over-year declines from some Asian routes due to trade war uncertainty and frontloading, though other markets are strengthening. In response to this shifting landscape, DHL is strategically investing by hiring over 200 customs agents to manage complexity, expanding capacity, and targeting growth sectors such as life sciences, pharmaceuticals (driven by reshoring), and the booming AI infrastructure (data centers, cloud logistics), signaling a major adaptation to evolving global trade dynamics and technological advancements.

Analysis

The traditional peak shipping season is experiencing an unprecedented disruption, characterized by what DHL Global Forwarding's CEO terms "incredibly soft" volumes into the United States. Trade routes from some parts of Asia to the U.S. have seen year-over-year declines as high as 20%, a direct result of trade policy uncertainty and the pull-forward effect of freight surges earlier in the year to pre-empt tariffs. In response to this volatile environment, DHL is executing a strategic pivot away from stagnating trade lanes and toward new growth opportunities. The company is making significant investments to capitalize on trade complexity by hiring over 200 customs agents, which will increase its global forwarding division's capacity in this area by nearly 40%. This move aims to establish a high-value service offering for importers navigating changing regulations. Furthermore, DHL is strategically targeting secular growth sectors, including life sciences and pharmaceuticals, which are benefiting from supply chain reshoring—a trend underscored by Eli Lilly's $5 billion domestic investment. The company is also aggressively pursuing opportunities tied to the AI infrastructure boom, investing in services to support the rapid build-out of data centers and cloud logistics, a growing market segment corroborated by Wells Fargo's supply chain financing data.